Renal Denervation-"Gizmo Idolatry" Fact Checker.
Journal: Journal of clinical hypertension (Greenwich, Conn.)
Year: March 05, 2025
Authors: Markus Schlaich, Murray Esler
Cardiologist
Markus P. Schlaich
PhD; BSc (Honours); ESH-accredited Hypertension Specialist
Perth
Connect with Markus P. Schlaich
Quick Appointment for Markus P. Schlaich
No OPD information available
Services Offered by Markus P. Schlaich
Hypertension
Renovascular Hypertension
Abdominal Obesity Metabolic Syndrome
Cardiac Ablation
Low Blood Pressure
Metabolic Syndrome
Obesity
Type 2 Diabetes (T2D)
Vasoconstriction
Acute Arterial Occlusion of Kidney
Arrhythmias
Atrial Fibrillation
Calcinosis
Carotid Artery Disease
Carotid Artery Surgery
Chronic Kidney Disease
Coronary Artery Spasm
COVID-19
Deep Brain Stimulation
Diabetic Nephropathy
Diabetic Retinopathy
Ectopic Heartbeat
End-Stage Renal Disease (ESRD)
Familial Dysautonomia
Familial Hypercholesterolemia
Heart Attack
Heart Failure
High Cholesterol
Hyperaldosteronism
Hypertensive Heart Disease
Loin Pain Hematuria Syndrome
Necrosis
Non-Alcoholic Fatty Liver Disease
Obstructive Sleep Apnea
Orthostatic Hypotension
Osteoporosis
Polycystic Kidney Disease
Postural Orthostatic Tachycardia Syndrome (POTS)
Severe Acute Respiratory Syndrome (SARS)
Stroke
Transient Ischemic Attack (TIA)
Type 1 Diabetes (T1D)
Wilson Disease
About Of Markus P. Schlaich
Markus P. Schlaich is a male doctor who helps people with various health issues like high blood pressure, obesity, diabetes, heart problems, and kidney diseases. He also works on things like sleep apnea, bone health, and eye problems related to diabetes. Markus P. Schlaich is a specialist in treating these conditions and has special skills to help patients feel better.
Markus P. Schlaich talks to patients in a way that makes them feel comfortable and safe. Patients trust him because he listens to their concerns and explains things clearly. He cares about their well-being and works hard to find the best treatment for each person.
Markus P. Schlaich stays updated on the latest medical knowledge and research to give the best care to his patients. He reads new studies and attends conferences to learn from other experts in the medical field. This helps him provide the most effective treatments for his patients.
Markus P. Schlaich works well with other medical professionals to give patients the best care possible. He shares information and collaborates with colleagues to find the right solutions for each patient's health needs. By working together, they can offer comprehensive care to those in need.
Markus P. Schlaich's work has had a positive impact on many patients' lives. His treatments have helped people manage their health conditions better and improve their quality of life. Patients have seen improvements in their blood pressure, diabetes, heart health, and overall well-being because of his care.
One of Markus P. Schlaich's notable publications is about renal denervation, a treatment for high blood pressure. He is also involved in a global clinical study to improve treatment for patients with uncontrolled hypertension. These efforts show his commitment to advancing medical knowledge and finding better ways to help patients live healthier lives.
Education of Markus P. Schlaich
PhD; University of Melbourne
BSc (Honours); University of Melbourne
ESH-accredited Hypertension Specialist; European Society of Hypertension
Memberships of Markus P. Schlaich
European Society of Hypertension (ESH)
Council of the International Society of Hypertension (ISH)
The High Blood Pressure Research Council of Australia
High Blood Pressure Research Council of Australia
Publications by Markus P. Schlaich
Supine Blood Pressure and Cardiovascular Risk.
Journal: JAMA Cardiology
Year: July 02, 2025
Authors: Janis Nolde, Marcio Kiuchi, Markus Schlaich
Endothelin Receptor Antagonists for the Treatment of Hypertension: Recent Data from Clinical Trials and Implementation Approach.
Journal: Current Cardiology Reports
Year: June 19, 2025
Authors: Revathy Manickavasagar, Anoushka Krishnan, Omar Azzam, Markus Schlaich
Description:Objective: The endothelin system is a highly relevant component of the pathophysiology of hypertension, which is currently unopposed by existing treatment approaches. We examined the role of dual endothelin receptor antagonists in the treatment of resistant hypertension. Results: The recent PRECISION trial demonstrated significant blood pressure lowering effect with the use of the dual endothelin receptor antagonist aprocitentan in the treatment of resistant hypertension. Aprocitentan was shown to be particularly effective in patients over 75 years of age, African-American patients, and patients with diabetes and advanced CKD. There was also a decrease in proteinuria. Aprocitentan was well tolerated and the risk of fluid retention can be mitigated by close clinical monitoring and titration of diuretic therapy. Aprocitentan presents a novel treatment option for resistant hypertension, with particular efficacy noted in patient cohorts who have historically been challenging to achieve blood pressure targets in.
Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage: The Global Burden of Disease Study 2021.
Journal: JAMA Neurology
Year: May 23, 2025
Authors: Victor Volovici, Benjamin Stark, Catherine Johnson, Jaakko Kaprio, Miikka Korja, Rita Krishnamurthi, Balakrishnan Nair, Annemarei Ranta, Gabriel J Rinkel, Mervyn D Vergouwen, Yohannes Abate, Hedayat Abbastabar, Foad Abd Allah, Atef Abdelkader, Parsa Abdi, Arash Abdollahi, Auwal Abdullahi, Olugbenga Abiodun, Richard Aboagye, Mohamed Abouzid, Dariush Abtahi, Samir Abu Rumeileh, Ahmed Abualhasan, Hasan Abualruz, Hana Abukhadijah, Ahmed Abu Zaid, Lawan Adamu, Isaac Addo, Rufus Adedoyin, Oyelola Adegboye, Saryia Adra, Leticia Adzigbli, Williams Agyemang Duah, Bright Ahinkorah, Aqeel Ahmad, Danish Ahmad, Amir Ahmadzade, Ali Ahmed, Haroon Ahmed, Syed Ahmed, Budi Aji, Mohammed Akkaif, Yazan Al Ajlouni, Ziyad Al Aly, Mohammed Albashtawy, Mohammed Ali, Sheikh Alif, Yousef Alimohamadi, Syed Aljunid, Mahmoud Alomari, Ahmad Alrawashdeh, Mohammed Alsabri, Rustam Salman, Awais Altaf, Alaa Al Tammemi, Nelson Alvis Guzman, Hassan Alwafi, Mohammad Al Wardat, Yaser Al Worafi, Hany Aly, Mohammad Sharif Alyahya, Karem Alzoubi, Reza Amani, Tarek Amin, Alireza Amindarolzarbi, Ganiyu Amusa, Deanna Anderlini, Dhanalakshmi Angappan, Abhishek Anil, Boluwatife Anuoluwa, Saleha Anwar, Anayochukwu Anyasodor, Geminn Louis Apostol, Jalal Arabloo, Demelash Areda, Johan Ärnlöv, Anton Artamonov, Kurnia Artanti, Ashokan Arumugam, Zahra Aryan, Mohammad Asghari Jafarabadi, Mubarek Ashemo, Tahira Ashraf, Mohammad Athar, Seyyed Athari, Avinash Aujayeb, Adedapo Awotidebe, Sina Azadnajafabad, Shahkaar Aziz, Ahmed Azzam, Giridhara Babu, Nasser Bagheri, Pegah Bahrami Taghanaki, Saeed Bahramian, Ruhai Bai, Atif Baig, Abdulaziz Bako, Ovidiu Baltatu, Kiran Bam, Maciej Banach, Soham Bandyopadhyay, Biswajit Banik, Mainak Bardhan, Suzanne Barker Collo, Till Bärnighausen, Hiba Barqawi, Lingkan Barua, Mohammad-mahdi Bastan, Sanjay Basu, Shelly Bell, Isabela Bensenor, Alemshet Berhie, Kebede Beyene, Akshaya Bhagavathula, Sonu Bhaskar, Ajay Bhat, Vivek Bhat, Gurjit Bhatti, Jasvinder Bhatti, Ali Bijani, Boris Bikbov, Mekuriaw Birhan, Mulugeta Birhanu, Veera Bitra, Archith Boloor, Hamed Borhany, Susanne Breitner, Hermann Brenner, Raffaele Bugiardini, Norma Bulamu, Zahid Butt, Lucas Cabral, Florentino Caetano Dos Santos, Daniela Calina, Luis Cámera, Luciana Campos, Ismael Campos Nonato, Angelo Capodici, Felix Carvalho, Carlos Castañeda Orjuela, Alberico Catapano, Luca Cegolon, Joshua Chadwick, Chiranjib Chakraborty, Promit Chakraborty, Sandip Chakraborty, Rama Chandika, Gashaw Chanie, Vijay Chattu, Anis Chaudhary, Gerald Chi, Fatemeh Chichagi, Patrick Ching, Hitesh Chopra, Sonali Choudhari, Enayet Chowdhury, Dinh-toi Chu, Sheng-chia Chung, Alyssa Columbus, Michael Criqui, Alanna Da Silva, Mohammad Dabbagh Ohadi, Omid Dadras, Xiaochen Dai, Koustuv Dalal, Lachlan Dalli, Emanuele D'amico, Mohsen Dashti, Kairat Davletov, Vanessa De La Cruz Góngora, Shayom Debopadhaya, Ivan Delgado Enciso, Emina Derviševic, Vinoth Gnana Devanbu, Syed Masudur Dewan, Amol Dhane, Mahmoud Dibas, Thanh Do, Thao Huynh Do, Sushil Dohare, Mohamed Doheim, Klara Dokova, Deepa Dongarwar, Mario D'oria, Ojas Doshi, Rajkumar Doshi, Robert Dowou, Haneil Dsouza, Siddhartha Dutta, Arkadiusz Dziedzic, Abdel E'mar, David Edvardsson, Defi Efendi, Ferry Efendi, Nevine El Nahas, Islam Elgendy, Muhammed Elhadi, Chadi Eltaha, Mohd Eltahir, Theophilus Emeto, Natalia Fabin, Adeniyi Fagbamigbe, Ayesha Fahim, Ildar Fakhradiyev, Jawad Fares, Pawan Faris, Nelsensius Fauk, Timur Fazylov, Ginenus Fekadu, Nuno Ferreira, Getahun Fetensa, Florian Fischer, Matteo Foschi, Ni Kadek Fridayani, Abduzhappar Gaipov, Avi Gajjar, Aravind Gandhi, Balasankar Ganesan, Ravindra Garg, Miglas Gebregergis, Mesfin Gebrehiwot, Teferi Gebremeskel, Molla Getie, Delaram Ghadimi, Fataneh Ghadirian, Sulmaz Ghahramani, Afsaneh Ghasemzadeh, Ramy Ghazy, Maryam Gholamalizadeh, Sherief Ghozy, Artyom Gil, Jaleed Gilani, Elena Gnedovskaya, Pouya Goleij, Alessandra Goulart, Barbara Niegia Goulart, Shi-yang Guan, Sapna Gupta, Farrokh Habibzadeh, Mostafa Hadei, Najah Hadi, Samer Hamidi, Nasrin Hanifi, Graeme Hankey, Netanja Harlianto, Josep Haro, Faizul Hasan, Hamidreza Hasani, Md Hasnain, Mahgol Hassan Zadeh Tabatabaei, Johannes Haubold, Rasmus Havmoeller, Simon Hay, Youssef Hbid, Golnaz Heidari, Mohammad Heidari, Mehdi Hemmati, Yuta Hiraike, Nguyen Hoan, Ramesh Holla, Mehdi Hosseinzadeh, Sorin Hostiuc, Junjie Huang, Hong-han Huynh, Bing-fang Hwang, Segun Ibitoye, Nayu Ikeda, Adalia Ikiroma, Mehran Ilaghi, Olayinka Ilesanmi, Irena Ilic, Milena Ilic, Md Islam, Nahlah Ismail, Hiroyasu Iso, Gaetano Isola, Masao Iwagami, Louis Jacob, Abdollah Jafarzadeh, Akhil Jain, Ammar Jairoun, Mihajlo Jakovljevic, Abubakar Jatau, Talha Jawaid, Sathish Jayapal, Jost Jonas, Nitin Joseph, Mikk Jürisson, Vidya Kadashetti, Rizwan Kalani, Vineet Kamal, Arun Kamireddy, Tanuj Kanchan, Himal Kandel, Jafar Karami, Ibraheem Karaye, Yeganeh Karimi, Arman Karimi Behnagh, Faizan Kashoo, Gbenga Kayode, Foad Kazemi, Emmanuelle Kesse Guyot, Yousef Khader, Inn Khaing, Fayaz Khan, Mohammad Khan, Haitham Khatatbeh, Moawiah Khatatbeh, Hamid Khayat Kashani, Khalid Kheirallah, Feriha Khidri, Moein Khormali, Atulya Khosla, Kwanghyun Kim, Yun Kim, Adnan Kisa, Sezer Kisa, Mika Kivimäki, Ali-asghar Kolahi, Farzad Kompani, Oleksii Korzh, Karel Kostev, Nikhil Kothari, Kewal Krishan, Varun Krishna, Vijay Krishnamoorthy, Mohammed Kuddus, Mukhtar Kulimbet, Setor Kunutsor, Maria Kurniasari, Dian Kusuma, Ville Kytö, Carlo La Vecchia, Chandrakant Lahariya, Daphne Teck Lai, Hanpeng Lai, Tri Laksono, Tea Lallukka, Kamaluddin Latief, Kaveh Latifinaibin, Nhi Huu Le, Thao Thi Le, Munjae Lee, Seung Lee, Wei-chen Lee, Yo Lee, Jacopo Lenzi, Matilde Leonardi, Ming-chieh Li, Xiaopan Li, Stephen Lim, Jialing Lin, Xuefeng Liu, Valerie Lohner, László Lorenzovici, Paulo Lotufo, Giancarlo Lucchetti, Jay Lusk, Ricardo Lutzky Saute, Hawraz M Amin, Armaan Malhotra, Kashish Malhotra, Ahmad Malik, Deborah Malta, Mohammad Mansournia, Lorenzo Mantovani, Emmanuel Manu, Hamid Marateb, Mirko Marino, Seyed Maroufi, Ramon Martinez Piedra, Santi Martini, Miquel Martorell, Roy Marzo, Yasith Mathangasinghe, Elezebeth Mathews, Andrea Maugeri, Steven Mcphail, Asim Mehmood, Man Mehndiratta, Kamran Mehrabani Zeinabad, Ritesh Menezes, Sultan Meo, Atte Meretoja, Tomislav Mestrovic, Chamila Dinushi Mettananda, Tomasz Miazgowski, Ana Micheletti Gomide Nogueira De Sá, Giuseppe Minervini, Le Huu Minh, Andreea Mirica, Erkin Mirrakhimov, Mohammad Mirza Aghazadeh Attari, Ajay Mishra, Prasanna Mithra, Abdalla Mohamed, Ahmed Mohamed, Ameen Mohammad, Soheil Mohammadi, Abdollah Mohammadian Hafshejani, Shafiu Mohammed, Ali Mokdad, Sabrina Molinaro, Shaher Momani, Mohammad Moni, Amirali Moodi Ghalibaf, Maryam Moradi, Yousef Moradi, Paula Moraga, Lidia Morawska, Ahmed Msherghi, Kavita Munjal, Christopher J Murray, Ahamarshan Nagarajan, Ganesh Naik, Soroush Najdaghi, Noureddin Nakhostin Ansari, Shumaila Nargus, Delaram Davani, Zuhair Natto, Javaid Nauman, Vinod Nayak, Athare Nazri Panjaki, Ruxandra Negoi, Soroush Nematollahi, Charles Richard Newton, Duc Nguyen, Hau Thi Nguyen, Hien Nguyen, Phat Nguyen, Van Nguyen, Robina Niazi, Yeshambel Nigatu, Ali Nikoobar, Antonio Nogueira De Sá, Shuhei Nomura, Jean Noubiap, Fred Nugen, Chimezie Nzoputam, Bogdan Oancea, Michael Oduro, Tolulope Ojo Akosile, Hassan Okati Aliabad, Sylvester Okeke, Akinkunmi Okekunle, Andrew Olagunju, Muideen Olaiya, Arão Oliveira, Gláucia Maria Oliveira, Abdulhakeem Olorukooba, Isaac Olufadewa, Raffaele Ornello, Esteban Ortiz Prado, Uchechukwu Osuagwu, Amel Ouyahia, Mayowa Owolabi, Ahmad Ozair, Mahesh P A, Alicia Padron Monedero, Jagadish Padubidri, Demosthenes Panagiotakos, Georgios Panos, Leonidas Panos, Ioannis Pantazopoulos, Romil Parikh, Seoyeon Park, Jay Patel, Urvish Patel, Dimitrios Patoulias, Paolo Pedersini, Emmanuel Peprah, Gavin Pereira, Arokiasamy Perianayagam, Norberto Perico, Simone Perna, Fanny Petermann Rocha, Anil Philip, Michael Piradov, Evgenii Plotnikov, Roman Polibin, Maarten Postma, Jalandhar Pradhan, Manya Prasad, Jagadeesh Puvvula, Nameer Qasim, Gangzhen Qian, Alberto Raggi, Fakher Rahim, Vafa Rahimi Movaghar, Mosiur Rahman, Muhammad Rahman, Amir Rahmani, Mohammad Rahmanian, Sathish Rajaa, Ali Rajabpour Sanati, Pushp Rajpoot, Prashant Rajput, Mahmoud Ramadan, Shakthi Ramasamy, Sheena Ramazanu, Amey Rane, Sina Rashedi, Mohammad-mahdi Rashidi, Devarajan Rathish, Salman Rawaf, Christian Razo, Murali Mohan Rama Reddy, Elrashdy Redwan, Giuseppe Remuzzi, Nazila Rezaei, Negar Rezaei, Mohsen Rezaeian, Hermano Alexandre Rocha, Jefferson Antonio Rodriguez, Leonardo Roever, Michele Romoli, Marina Romozzi, Allen Ross, Himanshu Rout, Nitai Roy, Priyanka Roy, Aly M Saad, Zahra Saadatian, Siamak Sabour, Simona Sacco, Basema Saddik, Erfan Sadeghi, Usman Saeed, Fatemeh Saheb Sharif Askari, Amirhossein Sahebkar, Pragyan Sahoo, Refat Uz Sajib, Luciane Salaroli, Mohamed Saleh, Yoseph Samodra, Vijaya Samuel, Abdallah Samy, Milena Santric Milicevic, Aswini Saravanan, Tanmay Sarkar, Gargi Sarode, Sachin Sarode, Benn Sartorius, Maheswar Satpathy, Markus Schlaich, Ione Jayce Schneider, Art Schuermans, Siddharthan Selvaraj, Subramanian Senthilkumaran, Sadaf Sepanlou, Yashendra Sethi, Allen Seylani, Ahmed Shaaban, Mahan Shafie, Moyad Shahwan, Masood Shaikh, Summaiya Shaikh, Muhammad Shamim, Anas Shamsi, Alfiya Shamsutdinova, Mohd Shanawaz, Mohammed Shannawaz, Amin Sharifan, Javad Sharifi Rad, Vishal Sharma, Bereket Shashamo, Mahabalesh Shetty, Premalatha Shetty, Mika Shigematsu, Aminu Shittu, Ivy Shiue, Nathan Shlobin, Seyed Shorofi, Emmanuel Siddig, Baljinder Singh, Paramdeep Singh, Puneetpal Singh, Surjit Singh, Farrukh Sobia, Ranjan Solanki, Shipra Solanki, Soroush Soraneh, Michael Spartalis, Suresh Srinivasamurthy, Jeffrey Stanaway, Muhammad Stanikzai, Antonina Starodubova, Jing Sun, Zhong Sun, Chandan Swain, Lukasz Szarpak, Payam Tabaee Damavandi, Seyyed Tabatabaei, Seyed-amir Tabatabaeizadeh, Celine Tabche, Jabeen Taiba, Iman Talaat, Jacques Tamuzi, Ker-kan Tan, Mohamad-hani Temsah, Masayuki Teramoto, Ramna Thakur, Kavumpurathu Thankappan, Rasiah Thayakaran, Sathish Thirunavukkarasu, Jansje Henny Ticoalu, Krishna Tiwari, Marcello Tonelli, Roman Topor Madry, Marcos Tovani Palone, An Tran, Jasmine Tran, Thang Tran, Nguyen Tran Minh Duc, Thomas Truelsen, Thien Tan Tri Truyen, Daniel Tsai, Atta Ullah, Brigid Unim, Bhaskaran Unnikrishnan, Carolyn Unsworth, Jibrin Usman, Sanaz Vahdati, Asokan Vaithinathan, Rohollah Valizadeh, Jef Van Den Eynde, Joe Varghese, Tommi Vasankari, Narayanaswamy Venketasubramanian, Dominique Vervoort, Jorge Villafañe, Manish Vinayak, Sergey Vladimirov, Hatem Wafa, Yasir Waheed, Waseem Wahood, Mandaras Walde, Yanzhong Wang, Nuwan Wickramasinghe, Peter Willeit, Asrat Wolde, Charles D Wolfe, Yihun Wubie, Hong Xiao, Suowen Xu, Xiaoyue Xu, Kazumasa Yamagishi, Yuichiro Yano, Amir Yarahmadi, Habib Yaribeygi, Sanni Yaya, Pengpeng Ye, Dong Yon, Naohiro Yonemoto, Chuanhua Yu, Aurora Zanghì, Iman Zare, Michael Zastrozhin, Chen Zhang, Yunquan Zhang, Zhi-jiang Zhang, Zhiqiang Zhang, Hanqing Zhao, Shang Zhou, Abzal Zhumagaliuly, Hafsa Zia, Magdalena Zielinska, Samer Zyoud, Gregory Roth, Valery Feigin
Description:Nontraumatic subarachnoid hemorrhage (SAH) represents the third most common stroke type with unique etiologies, risk factors, diagnostics, and treatments. Nevertheless, epidemiological studies often cluster SAH with other stroke types leaving its distinct burden estimates obscure. To estimate the worldwide burden of SAH. Based on the repeated cross-sectional Global Burden of Disease (GBD) 2021 study, the global burden of SAH in 1990 to 2021 was estimated. Moreover, the SAH burden was compared with other diseases, and its associations with 14 individual risk factors were investigated with available data in the GBD 2021 study. The GBD study included the burden estimates of nontraumatic SAH among all ages in 204 countries and territories between 1990 and 2021. SAH and 14 modifiable risk factors. Absolute numbers and age-standardized rates with 95% uncertainty intervals (UIs) of SAH incidence, prevalence, mortality, and disability-adjusted life-years (DALYs) as well as risk factor-specific population attributable fractions (PAFs). In 2021, the global age-standardized SAH incidence was 8.3 (95% UI, 7.3-9.5), prevalence was 92.2 (95% UI, 84.1-100.6), mortality was 4.2 (95% UI, 3.7-4.8), and DALY rate was 125.2 (95% UI, 110.5-142.6) per 100 000 people. The highest burden estimates were found in Latin America, the Caribbean, Oceania, and high-income Asia Pacific. Although the absolute number of SAH cases increased, especially in regions with a low sociodemographic index, all age-standardized burden rates decreased between 1990 and 2021: the incidence by 28.8% (95% UI, 25.7%-31.6%), prevalence by 16.1% (95% UI, 14.8%-17.7%), mortality by 56.1% (95% UI, 40.7%-64.3%), and DALY rate by 54.6% (95% UI, 42.8%-61.9%). Of 300 diseases, SAH ranked as the 36th most common cause of death and 59th most common cause of DALY in the world. Of all worldwide SAH-related DALYs, 71.6% (95% UI, 63.8%-78.6%) were associated with the 14 modeled risk factors of which high systolic blood pressure (population attributable fraction [PAF] = 51.6%; 95% UI, 38.0%-62.6%) and smoking (PAF = 14.4%; 95% UI, 12.4%-16.5%) had the highest attribution. Although the global age-standardized burden rates of SAH more than halved over the last 3 decades, SAH remained one of the most common cardiovascular and neurological causes of death and disabilities in the world, with increasing absolute case numbers. These findings suggest evidence for the potential health benefits of proactive public health planning and resource allocation toward the prevention of SAH.
Automated office blood pressure measurement: a Hypertension Australia and National Hypertension Taskforce of Australia position statement.
Journal: Journal Of Hypertension
Year: May 06, 2025
Authors: James Sharman, Aletta Schutte, Mark Nelson, Ania Samarawickrama, Nigel Stocks, Charlotte Hespe, Tim Usherwood, Michael Stowasser, Anthony Rodgers, Natalie Ward, Elizabeth Halcomb, Sharon James, Garry Jennings, Markus Schlaich
Description:Hypertension is the most common problem managed in Australian general practice, yet most adults with hypertension do not have their blood pressure (BP) treated to target. Hypertension diagnosis and management rely upon accurate BP measurements performed using a standardised protocol. However, health system barriers prevent doctors from following measurement protocols, leading to inaccurate BP assessments. A practical BP measurement protocol that can be widely implemented is urgently warranted. Automated office BP (AOBP) is the recommended measurement standard for the diagnosis and management of hypertension. AOBP involves using a validated automated upper-arm cuff BP device programmed to record multiple BP readings at set intervals starting after a rest period. It is done by a trained operator using a standardised protocol in a quiet setting with the correct patient setup, no distractions, and in the absence of a doctor. The device automatically calculates the average of the AOBP recordings and this is comparable to the 24-h ambulatory BP daytime mean. The hypertension threshold based on AOBP is 135/85 mmHg. AOBP can also be applied in other community settings (e.g. pharmacies), provided all the above criteria are met along with communication of results to the person's usual general practitioner. In Australia, nation-wide systematic implementation of evidence based AOBP measurement is strongly recommended. This standardised approach will support healthcare professionals, especially general practitioners, in obtaining high-quality BP values with increasing confidence in clinical decision-making. Policy and practice changes, to address barriers and provide enabling mechanisms for sustained implementation of AOBP, are required.
Clinical Trials by Markus P. Schlaich
Global Clinical Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension on Standard Medical Therapy (SPYRAL HTN-ON MED)
Enrollment Status: Active not recruiting
Published: April 13, 2025
Intervention Type: Device, Procedure
Study Drug:
Study Phase: Not Applicable
Sympathetic Nervous System Inhibition for the Treatment of Diabetic Nephropathy
Enrollment Status: Completed
Published: September 14, 2023
Intervention Type: Drug
Study Drug: Moxonidine
Study Phase: Phase 4
Interactions Between The Serotonin Transporter And Sympathetic Nervous System Activation In Patients With Major Depressive Disorder - Understanding The Link Between The Brain And The Heart
Enrollment Status: Completed
Published: September 14, 2023
Intervention Type: Drug
Study Drug: Selective Serotonin Re-Uptake Inhibitor (SSRI) Antidepressant
Study Phase: Phase 4
A Randomised Trial Examining the Effectiveness of Sympathetic Nervous Inhibition in Alleviating the Metabolic Side Effects of Antipsychotic Medications in Patients With Schizophrenia
Enrollment Status: Withdrawn
Published: April 24, 2019
Intervention Type: Drug
Study Drug:
Study Phase: Phase 4
Reveal LINQ™ Evaluation of Fluid
Enrollment Status: Terminated
Published: April 05, 2019
Intervention Type: Device
Study Drug:
Study Phase: Not Applicable
Frequently Asked Questions About Markus P. Schlaich
What conditions does Markus P. Schlaich specialize in treating as a cardiologist?
Markus P. Schlaich specializes in treating a wide range of cardiovascular conditions such as hypertension, heart failure, arrhythmias, and coronary artery disease.
What diagnostic tests and procedures does Markus P. Schlaich offer in his practice?
Markus P. Schlaich offers diagnostic tests and procedures including echocardiograms, stress tests, cardiac catheterization, and ambulatory blood pressure monitoring.
How does Markus P. Schlaich approach the treatment of hypertension in his patients?
Markus P. Schlaich takes a comprehensive approach to treating hypertension, which may include lifestyle modifications, medication management, and in some cases, minimally invasive procedures like renal denervation.
What are some common risk factors for heart disease that Markus P. Schlaich addresses with his patients?
Markus P. Schlaich addresses common risk factors for heart disease such as high blood pressure, high cholesterol, smoking, obesity, and a sedentary lifestyle through personalized treatment plans.
Can Markus P. Schlaich provide guidance on heart-healthy lifestyle changes for his patients?
Yes, Markus P. Schlaich offers guidance on heart-healthy lifestyle changes including diet modifications, exercise recommendations, stress management techniques, and smoking cessation support.
How does Markus P. Schlaich stay current with the latest advancements and research in the field of cardiology?
Markus P. Schlaich stays current with the latest advancements and research in cardiology through ongoing medical education, participation in clinical trials, and collaboration with other experts in the field.
More Cardiologist Like Markus P. Schlaich in Perth
